March 28th 2023
Your daily dose of clinical news you may have missed.
March 27th 2023
Adding paired serology and sputum to nasal swab/nasopharyngeal swabs RT-PCR increased RSV detection by 50% to 66% on average, respectively.
March 22nd 2023
Drug-resistant cases of Candida auris continue to spread across the US after an alarming 95% rise in cases of the fungal infection in 2021.
March 17th 2023
The 5-in-1 vaccine candidate, if approved, would provide the broadest meningococcal serogroup coverage and simplify the vaccination schedule.
March 15th 2023
The FDA authorized Pfizer's bivalent vaccine as a booster dose for children aged under 5 years who received 3 doses of monovalent vaccine.
5 Clinical Updates in Tick-borne Disease Research
Lyme disease vaccine being tested in phase 3 trial, Lyme disease diagnoses up 357%, and 3 more updates on tick-borne diseases.
FDA EUA for Monkeypox Virus Vaccine Expands Available Doses by 5-Fold
A smaller dose given by intradermal injection will expand the total US supply by a factor of 5, FDA says.
Monkeypox Declared US Public Health Emergency by HHS
Monkeypox will now be treated as a public health emergency in the US where the outbreak has become the largest in the world, according to authorities.
Impact of HPV Vaccination in US is Rising, and Herd Immunity is Getting Stronger, According to New Research
Investigators from CDC warned, however, that HPV vaccinations missed due to the COVID-19 pandemic could stymie this progress.
Polio Case in the US in Same NY Community that Harbored Measles Outbreak in 2018-19
The first US polio case in more than a decade was found in vaccination-poor Rockland County, NY, where the virus has now been found in wastewater.
A Fever of Unknown Origin: When a Thorough History is an Afterthought
When a workup begins with lab tests a thorough history can be an afterthought. Before this patient had a blind liver biopsy, case author Dr Rodger MacArthur asked some simple questions.
Monkeypox Quick Take: What do Americans Think, Believe, Fear?
A new survey of monkeypox outbreak perceptions among US adults offers primary care clinicians a quick take on what their patients may be thinking.
COVID-19 Update: US Vaccinations, Booster Doses, & Global Data as of July 27, 2022
Data from the CDC on US vaccination and booster shot rates and from the Johns Hopkins COVID-19 interactive map on cases and deaths in the US and worldwide.
COVID-19 Update: US Vaccinations, Booster Doses, & Global Data as of July 26, 2022
Data from the CDC on boosters and US vaccination rates and from the Johns Hopkins COVID-19 interactive map on cases and deaths in the US and worldwide.
Monkeypox Virus Questions & Answers for Family Physicians: Highlights from an AAFP Conversation
A public health expert sat down with the American Academy of Family Physicians to answer some common questions about the virus. Get the topline, here.
Monkeypox: WHO Declares Public Health Emergency of International Concern
The WHO's highest level of alert indicates the organization's belief that the now multicountry monkeypox outbreak requires a coordinated international response.
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of July 22, 2022
Risks for Diabetes and CVD Spike in Early COVID-19 Infection, May Diminish Over 12 Months
Type 1 diabetes diagnoses increased by 81% during the 4-week acute phase of COVID-19 in UK patients and CVD diagnoses rose 6-fold, according to a large population-based study.
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of July 20, 2022
Monkeypox Treatments May be Close at Hand
There are no specific drugs to treat the monkeypox virus but research into existing antivirals is well under way to determine their potential efficacy.
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of July 19, 2022
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of July 18, 2022
Refugee Immunization Requirements: A Pop Quiz
Refresh your memory on refugee immunization recommendations with a 3-question quiz based on a patient scenario.
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of July 13, 2022
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of July 12, 2022
Mayo Clinic Laboratories Begin Monkeypox Testing to Help Increase Access, Availability
Mayo Clinic Laboratory will use the CDC's orthopoxvirus test and expects to handle up to 10 000 tests per week.
Newer Omicron Subvariants Evade Neutralizing Antibodies from Vaccination and Prior Infection, Says New Research
Findings showed neutralizing antibody responses to BA.4 and BA.5 subvariants were approximately 20-fold lower than to the original WA1/2020 strain.
9 Lyme Disease Myths and Facts: A Misinformation Refresher for Primary Care
Lyme disease is surrounded by its own cloud of misinformation. Here are 9 myths you might hear from patients this summer plus the facts-at-a-glance for backup.
Monkeypox Testing in the US Set to Double, According to the CDC
Global life sciences company Labcorp began testing for monkeypox using the CDC’s orthopoxvirus test on Wednesday.
COVID-19 Third Leading Cause of Death in America in 2020 and 2021, Shows New Analysis
An analysis of US death certificate data found that COVID-19 was a top 5 cause of death in every age group aged 15 years and older.
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of July 6, 2022
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of June 30, 2022
FDA Recommends COVID-19 Booster Doses Optimized for Omicron Variant
The FDA recommended on Thursday the inclusion of a SARS-CoV-2 Omicron component in COVID-19 vaccine booster doses.
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of June 28, 2022
Substantial Drop in HIV Testing among Key Groups during First Year of COVID-19, New CDC Data Reveals
New data showed a sharp drop in HIV tests administered in health care and non-health care settings from 2019 to 2020—primarily among persons disproportionately affected by HIV.